Coronavirus Update: Gilead Publishes Promising Results on Remdesivir

The Street 2020-10-09

Views 1

Here's the latest on the coronavirus pandemic.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Gilead Publishes Year in Review 2016 (3) | Gilead
play
03:42

Gilead Publishes Year in Review 2016 (3) | Gilead
Gilead Publishes Year in Review 2016 | Gilead
play
03:23

Gilead Publishes Year in Review 2016 | Gilead
Gilead Publishes Year in Review 2016 (2) | Gilead
play
03:34

Gilead Publishes Year in Review 2016 (2) | Gilead
Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course
play
03:10

Gilead Sciences Inc’s antiviral remdesivir could be priced up to $5,080 per course
Gilead to expand availability of Remdesivir in India
play
00:34

Gilead to expand availability of Remdesivir in India
Remdesivir to arrive at hospitals this week, Gilead CEO says
play
01:43

Remdesivir to arrive at hospitals this week, Gilead CEO says
Remdesivir to arrive at hospitals this week, Gilead CEO says
play
01:43

Remdesivir to arrive at hospitals this week, Gilead CEO says
Gilead inks deals with generics drugmakers to supply remdesivir for 127 countries
play
00:47

Gilead inks deals with generics drugmakers to supply remdesivir for 127 countries
المدير العام لشركة Gilead لـCNBC عربية: عقار Remdesivir سيبقى له دور في معالجة مرضى كورونا حتى في حال ظهور لقاح
play
09:11

المدير العام لشركة Gilead لـCNBC عربية: عقار Remdesivir سيبقى له دور في معالجة مرضى كورونا حتى في حال ظهور لقاح
U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
play
02:22

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
play
00:35

U.S. FDA gives full approval to Gilead Sciences' antivirul drug Remdesivir as COVID-19 treatment
Gilead Donates Entire Remdesivir Supply
play
00:26

Gilead Donates Entire Remdesivir Supply